VY7523
VY7523-102
Phase 2 small_molecule active
Quick answer
VY7523 for Alzheimer's Disease (AD) is a Phase 2 program (small_molecule) at Voyager Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Voyager Therapeutics
- Indication
- Alzheimer's Disease (AD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active